Duchenne muscular dystrophy (DMD) is a fatal and incurable muscle degenerative disorder. We identify a function of the protease urokinase...
Array
(
[id_prestablog_news] => 126
[id_shop] => 1
[date] => 2007-09-04 00:00:00
[date_modification] => 2024-02-09 14:15:11
[langues] => ["1","2"]
[actif] => 1
[slide] => 0
[url_redirect] =>
[average_rating] =>
[number_rating] =>
[author_id] => 1
[featured] => 0
[ishero] => 0
[prim_key] => 249
[id_lang] => 1
[title] => uPA deficiency exacerbates muscular dystrophy in MDX mice-
[paragraph] => uPA deficiency exacerbates muscular dystrophy in MDX mice.
[content] => Authors
M. Suelves, B. Vidal, A. L. Serrano, M. Tjwa, J. Roma et al.
Lab
Program on Differentiation and Cancer and Program on Genes and Disease, Center for Genomic Regulation, Barcelona, Spain ; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Barcelona, Spain
Journal
JCB
Abstract
Duchenne muscular dystrophy (DMD) is a fatal and incurable muscle degenerative disorder. We identify a function of the protease urokinase plasminogen activator (uPA) in mdx mice, a mouse model of DMD. The expression of uPA is induced in mdx dystrophic muscle, and the genetic loss of uPA in mdx mice exacerbated muscle dystrophy and reduced muscular function. Bone marrow (BM) transplantation experiments revealed a critical function for BM-derived uPA in mdx muscle repair via three mechanisms: (1) by promoting the infiltration of BM-derived inflammatory cells; (2) by preventing the excessive deposition of fibrin; and (3) by promoting myoblast migration. Interestingly, genetic loss of the uPA receptor in mdx mice did not exacerbate muscular dystrophy in mdx mice, suggesting that uPA exerts its effects independently of its receptor. These findings underscore the importance of uPA in muscular dystrophy.
BIOSEB Instruments Used
Grip strength test (BIO-GS3)
Keywords/Topics
Duchenne muscular dystrophy; Muscular system
[meta_description] =>
[meta_keywords] => http://jcb.rupress.org/content/178/6/1039.abstract
[meta_title] =>
[link_rewrite] => upa-deficiency-exacerbates-muscular-dystrophy-in-mdx-mice-
[actif_langue] => 1
[read] => 1337
[count_comments] => 0
[id] => 126
[categories] => Array
(
[44] => Array
(
[id_prestablog_categorie] => 44
[title] => Duchenne muscular dystrophy
[link_rewrite] => Duchenne-muscular-dystrophy
)
[20] => Array
(
[id_prestablog_categorie] => 20
[title] => Muscular system
[link_rewrite] => Muscular-system
)
[2] => Array
(
[id_prestablog_categorie] => 2
[title] => Publications
[link_rewrite] => publications
)
)
[authors] =>
[paragraph_crop] => uPA deficiency exacerbates muscular dystrophy in MDX mice.
[link_for_unique] => 1
[products_liaison] => Array
(
[48] => Array
(
[name] => Grip strength test
[description_short] =>
An easy way to objectively quantify the muscular strength of mice and rats, and to assess the effect of drugs, toxins, muscular (i.e. myopathy) and neurodegenerative diseases on muscular degeneration. It is widely used in conjunction with the ROTAROD motor coordination test: a normally coordinated rodent will show a decreased latency to fall off the rotating rod if its muscular strength is low. The Grip Strength Test is a must for your research on activity, motor control & coordination, and is particularly well suited for studies on Parkinson's & Huntington's disease.
New features GS4 - 2023: Color display with permanent backlight screen for easier reading, reset by footswitch, Improved battery time, Larger data memory of 500 values, Animal counter, USB port (charging/data transfer)


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://bioseb.com/en/activity-motor-control-coordination/48-grip-strength-test.html
)
)
)
1 Read more